Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
2
F-Prime Capital, Novartis Venture Fund
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Advancing Accessible Solutions for Complex Neurodegenerative Diseases. Protecting neurons to advance treatment for neurodegenerative…
CND Life SciencesVenture round $8.6M · 19 mo ago • Founded 2017
CND advances neurodiagnostics through skin biopsy testing, including the Syn-One Test, for neurodegenerative diseases.
ABio-XFounded 2021
Join ABio-X: life sciences incubator driving novel drug discovery and company formation to address large, daunting diseases.
Vanqua BioVenture round $45M · 2 yr ago • Founded 2019 • 201-500 employees
Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.
GentiBioSeries A $157M · 5 yr ago
Our modular engineering platform allows us to create optimized Tregs phenotypes tailored to address a wide variety of autoimmune…
ElectronxSeries A $30M · 11 mo ago • 51-200 employees
ElectronX Receives CFTC Approval for Intermediated Market Access Read the Press Release The first U.S.-regulated, direct-access power…

Overview

Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.